Pioneer, visionary, innovator: all words that describe Dave Borden’s 40+ year career in the employee health and pharmacy benefits industry. A self-described “numbers guy,” Dave earned a BS in Finance from Haslam College of Business at the University of Tennessee before going into underwriting and actuary. His financial fluency caught the attention of leading firms like Arthur Andersen and Deloitte, but an entrepreneurial spirit drove Dave and several others to eventually strike out on their own. He served as Founder and CEO of Pharmaceutical Strategies Group (PSG) from 2004 to 2021 when PSG was acquired by EPIC Brokers.
Under Dave’s leadership, PSG accumulated a number of accolades and singular achievements:
Innovations to come out of PSG during Dave’s tenure include 90-day at retail, specialty pharmacy carve-out, split fill for high abandonment-rate medications and 30-day specialty limitations. Never content to stay static, Dave has also directed the firm to become an industry leader in 340B consulting and big-data analytics delivery and sold that division to Omnicell in 2020.
Few others offer the depth and diversity of PSG, which reflects Dave’s early and enduring vision for the organization: delivering value and getting results by staying two steps ahead of the industry.